The Japanese Association for Thoracic Surgery has conducted annual surveys of thoracic surgery throughout Japan since 1986 to determine the statistics regarding the number of procedures according to the operative category. Here, we have summarized the results from our annual survey of thoracic surgery performed during 2011.
The incidence of hospital mortality was added to the survey to determine the nationwide status, which can be useful not only for surgeons, who can better compare their work with that of others, but also for the Association, which can gain a better understanding of present problems as well as future prospects. Thirty-day mortality (sometimes termed ''operative mortality'') is death within 30 days of an operation regardless of the patient's geographic location and even though the patient had been discharged from the hospital within those 30 days.
Hospital mortality is death within any time interval after an operation if the patient had not been discharged from the hospital. Hospital-to-hospital transfer is not considered discharge; transfer to a nursing home or a rehabilitation unit is considered hospital discharge unless the patient subsequently dies of complications of the operation. (The definitions of terms are based on the published guidelines of the Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of the Society of Thoracic Surgeons and the American Association for Thoracic Surgery (Edmunds et al. Ann Thorac Surg 1996; 62:932-5; J Thorac Cardiovasc Surg 1996; 112:708-11) .
Thoracic surgery was classified into three categoriescardiovascular, general thoracic, and esophageal surgery-and the pertinent data were examined and analyzed for each group. Access to the computerized data is offered to all members of this Association. We honor and value your continued kind support and contributions (Tables 1, 2 ).
Final report (A) Cardiovascular surgery
First, we are very pleased with the high response rate to our survey of cardiovascular surgery (96.4 %), which definitely enhances the quality of this annual report. We very much appreciate the enormous effort put into completing the survey at each participating institution. Figure 1 shows the development of cardiovascular surgery in Japan over the last 26 years. Aneurysm surgery includes only operations for thoracic or thoracoabdominal aortic aneurysms. The number of pacemaker and assist device implantation operations is not included in the total number of surgical operations. A total of 60,284 cardiovascular operations were performed at 570 institutions during 2011 alone and included 31 cardiac transplantations, which were started in 1999. The number of operations for thoracic aortic aneurysm consistently increased, by 11.1 %, and that for valvular heart disease also increased, by 2.4 %, compared with 2010. Surgery for congenital heart disease slightly increased, by 3.1 %. By contrast, the number of operations for ischemic heart disease decreased by 8.0 % in 2011 compared with 2010.
Data for individual categories are summarized in Tables 1, 2 , 3, 4, 5, 6, 7. In 7, 435 open-heart operations performed for congenital heart disease, the overall hospital mortality was 2.4 %, which has varied little since 2005. Mitral valve repair constituted 29.2 % of all valvular heart disease operations (19, 164) , which is similar to that of the last 3 years. Aortic valve replacement with a bioprosthesis was performed in 7,531 cases, with the number consistently increasing. The hospital mortality rates associated with primary single valve replacement were 2.9 and 5.8 % for aortic and mitral valve replacement, respectively, while that for primary mitral valve repair was 1.5 %. However, hospital mortality rates for redo valve surgery were 8.4 and 7.6 % for aortic and mitral procedures, respectively.
Isolated coronary artery bypass grafting (CABG) was performed in 14,256 cases which is a decrease of 8.2 % compared with 15,521 in 2010.
The operative and hospital mortality rates associated with primary elective CABG procedures in 11,977 cases were 0.7 and 1.1 %, respectively. However, hospital mortality of primary emergency CABG in 2,236 cases was 7.6 %, which was still high. Off-pump coronary bypass grafting (OPCAB) was performed in 8,680 cases, constituting 60.9 % of the total isolated CABG procedures. The percentage of OPCAB cases among the total isolated CABG procedures has been at the same level since 2005.
A total of 1,321 patients underwent surgery for complications of myocardial infarction, including 362 operations for a left ventricular aneurysm or infarction and 316 operations for ischemic mitral regurgitation. Operations for thoracic aortic dissection were performed in 6,013 cases. For 3,839 type A acute aortic dissections, hospital mortality was 11.1 %, which was similar to that in 2010 (11.1 %). Operations for a nondissected thoracic aneurysm were carried out in 8,203 cases, with an overall hospital mortality of 6.7 %, which was same level as 6.3 % in 2010.
The hospital mortality associated with unruptured aneurysms was 3.9 %, and that for ruptured aneurysms was 22.2 %, which remains markedly high. The number of stent graft procedures remarkably increased. A total of 758 patients with aortic dissection underwent stent graft placement: transluminal stent grafting (TEVAR) in 590 cases, open stent grafting in 137 cases. The hospital mortality rates associated with TEVAR for type B aortic dissection were 7.7 and 1.1 %, for acute and chronic cases, respectively. A total of 3,972 patients with a nondissected aortic aneurysm underwent stent graft placement. The hospital mortality rates for TEVAR were 2.6 and 16.3 % for nonruptured and ruptured aneurysms, respectively.
In summary, the total cardiovascular operations increased during 2011 by 814 cases, with steadily improving results in almost all categories compared with those in 2010. 1986  1987  1988  1989  1990  1991  1992  1993  1994  1995  1996  1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 Gen Thorac Cardiovasc Surg (2013) 61:578-607 581 Values in parenthesis represent mortality % CPB cardiopulmonary bypass, PDA patient ductus arteriosus, VSD Table 1 continued ( Table 3 continued ( The total number of operations reported in 2011 in general thoracic surgery has reached 69,223. This is due to the steady increase in lung cancer surgery as last year (31,301, 2009; 32,801, 2010; 33,878, 2011) . Surgery for lung cancer consists more than 49 % of all the general thoracic surgery. Among lung cancer subtypes, adenocarcinoma consists of an overwhelming percentage of 68.8 % of the total lung cancer surgery. More and more lung cancer surgeries are being done using video-assisted thoracic surgery (VATS) and 62.9 % of the total lung cancer surgeries were done by VATS in 2011 VATS in (59.6 %, 2010 . The 30 day mortality of lung cancer patients undergoing lobectomy is as low as 0.3 % (0.4, 2010). Pneumonectomy was done in 596 patients with a hospital death of 1.8 (1.8, 2010) %. The number of sleeve lobectomy (403) has plummeted (441, 2009; 400, 2010) .
Interstitial pneumonia was the most frequent cause of death after lung cancer surgery and the top five causes of death after lung cancer surgery (interstitial pneumonia, pneumonia, respiratory failure, cardiovascular, bronchopleural fistula) have not been changed in these 3 years.
7,210 patients with metastatic pulmonary tumor were operated in 2011 and steady increase was observed (6,248, 2009; 6,748, 2010) . 77 % of these were operated using VATS.
90 tracheal tumors were operated in 2011. Adenoid cystic carcinoma and squamous cell carcinoma were frequent primary tracheal tumor.
434 tumors of pleural origin were operated in 2011. Diffuse malignant pleural mesothelioma was the most frequent histology. Extrapleural pneumonectomy was the most frequently chosen operative method (146 cases Values in parenthesis represent mortality % (Tables 3, 4 ). The decrease of registered patients with nonsurgically treated benign esophageal diseases is obvious during 2011. The patients registered, particularly those undergoing nonsurgical therapy for a malignant esophageal disease, have been increasing since 1990 (Fig. 1) . Among benign esophageal diseases (Table 2) , hiatal hernia, esophageal varices, achalasia and esophagitis (including reflux esophagitis) were the most common conditions in Japan. On the other hand, spontaneous rupture of the esophagus, benign esophageal tumors and congenital esophageal atresia were common diseases which were surgically treated as well as the abovementioned diseases. The thoracoscopic and/or laparoscopic procedures have been widely adopted for benign esophageal diseases, in particular achalasia, hiatal hernia and benign tumors. Open surgery was performed in 460 patients with a benign esophageal disease, with 30-day mortality in 7 (1.5 %), while thoracoscopic and/ or laparoscopic surgery was performed for 451 patients, with 1 (0.2 %) of the 30-day mortality. The difference in these death rates between open and scopic surgeries seems to be related to the conditions requiring open surgery.
The majority of malignant diseases were carcinomas (Table 3) . Among esophageal carcinomas, the incidence of squamous cell carcinoma was 92.4 %, while that of adenocarcinomas including Barrett cancer was 5.4 %. The resection rate for patients with a squamous cell carcinoma was 74.3 %, while that for patients with an adenocarcinoma was 88.9 %.
According to location, cancer in the thoracic esophagus was the most common (Table 4) . Of the 3,582 patients (37.3 % of total esophageal malignancies) having superficial esophageal cancers within mucosal and submucosal layers, 1,621 (45.3 %) patients underwent esophagectomy, while 1,766 (49.3 %) patients underwent EMR or ESD. The 30-day mortality rate and hospital mortality rate after esophagectomy for patients with a superficial cancer were 0.5 and 1.9 % respectively. There was no EMR or ESDrelated death. Advanced esophageal cancer invading deeper than the submucosal layer was observed in 5,979 (62.2 %) patients. Of the 5,979 patients with advanced esophageal cancer, 3,809 (63.7 %) underwent esophagectomy, with 0.8 % of the 30-day mortality rate and with 3.3 % of the hospital mortality rate.
Multiple primary cancers were observed in 1,504 (15.6 %) of all the 9,613 patients with esophageal cancer. Synchronous cancer was found in 974 (64.8 %) patients, while metachronous cancer (found before esophageal cancer) was observed in 907 (60.3 %) patients. The stomach is the commonest site for both synchronous and metachronous malignancy followed by head and neck cancer (Table 4) .
Among esophagectomy procedures, transthoracic esophagectomy through right thoracotomy was the most commonly adopted for patients with a superficial cancer as well as for those with an advanced cancer (Table 5) . Transhiatal esophagectomy commonly performed in Western countries was adopted in only 4.9 % of patients having a superficial cancer who underwent esophagectomy and in 1.9 % of those having an advanced cancer in Japan. The thoracoscopic and/or laparoscopic esophagectomy were adopted for 698 patients (43.1 %) with a superficial cancer, and for 844 patients (22.2 %) with an advanced cancer. The number of cases of thoracoscopic and/or laparoscopic surgery for superficial or advanced cancer has been increasing for these several years (Fig. 2) .
Combined resection of the neighboring organs during resection of an esophageal cancer was performed in 250 patients (Tables 5, 6 ). Resection of the aorta together with the esophagectomy was performed in 4 cases. Tracheal and/or bronchial resection combined with esophagectomy was performed in 26 patients, with the 30-day mortality rate at 0 % and the hospital mortality rate at 3.8 %. Lung resection combined with esophagectomy was performed in 41 patients, with the 30-day mortality rate at 0 % and the hospital mortality rate at 0 %. Salvage surgery after definitive (chemo-) radiotherapy was performed in 187 patients, with the 30-day mortality rate at 0.5 % and with the hospital mortality rate at 4.3 % (Table 5) .
Last, in spite of the efforts of the Committee to cover wider patient populations to this annual survey, the majority of the institutions which responded to the questionnaire were the departments of thoracic or esophageal surgery. It should be noted that larger number of patients with esophageal diseases should have been treated medically and endoscopically. We should continue our effort for complete survey through more active collaboration with the Japan Esophageal Society and other related societies. 
